Lipoprotein lipase in the arterial wall: Linking LDL to the arterial extracellular matrix and much more

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 2, 2002, Pages 211-217

  Pentikäinen, Markku O ^a   Oksjoki, Riina ^a   Öörni, Katariina ^a   Kovanen, Petri T ^a  

^a WIHURI RESEARCH INSTITUTE   (Finland)

Author keywords

Extracellular matrix; Lipoprotein lipase; Lipoproteins; Retention

Indexed keywords

LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; PROTEOGLYCAN;

ARTERY INTIMA; ARTERY WALL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; EXTRACELLULAR MATRIX; HUMAN; LIPID METABOLISM; LIPID STORAGE; PRIORITY JOURNAL;

ANIMALS; ARTERIES; ARTERIOSCLEROSIS; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; HUMANS; LIPOPROTEIN LIPASE; LIPOPROTEINS, LDL; TUNICA INTIMA;

EID: 0036161909     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/hq0102.101551     Document Type: Article

References (75)

1. Lipoprotein lipase and lipolysis: Central roles in lipoprotein metabolism and atherogenesis
2. Catalytically inactive lipoprotein lipase expression in muscle of transgenic mice increases very low density lipoprotein uptake: Direct evidence that lipoprotein lipase bridging occurs in vivo
3. Lipoprotein lipases and vitellogenins in relation to the known three-dimensional structure of pancreatic lipase
4. Lipoprotein lipase: Molecular model based on the pancreatic lipase x-ray structure: Consequences for heparin binding and catalysis
5. Structure of human pancreatic lipase
6. Structure, function and role of lipoprotein lipase in lipoprotein metabolism
7. A molecular biology-based approach to resolve the subunit orientation of lipoprotein lipase
8. Heparin-binding defective lipoprotein lipase is unstable and causes abnormalities in lipid delivery to tissues
9. Lipoprotein lipase in human plasma is mainly inactive and associated with cholesterol-rich lipoproteins
10. Forms of lipoprotein lipase in rat tissues: In adipose tissue the proportion of inactive lipase increases on fasting
11. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein
12. A proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceride-rich lipoproteins
13. The response-to-retention hypothesis of early atherogenesis
14. The response-to-retention hypothesis of athero-genesis reinforced
15. Association of apo B lipoproteins with arterial proteoglycans: Pathological significance and molecular basis
16. Initiation of atherosclerotic lesions in cholesterol-fed rabbits, I: Focal increases in arterial LDL concentration precede development of fatty streak lesions
17. Initiation of atherosclerotic lesions in cholesterol-fed rabbits, II: Selective retention of LDL vs. selective increases in LDL permeability in susceptible sites of arteries
18. Residence time of low-density lipoprotein in the normal and atherosclerotic rabbit aorta
19. Effects of injury on apoB kinetics and concentration in rabbit aorta
20. Regional differences in aortic synthesis of sulfated proteoglycans correlate with susceptibility to atherosclerosis
21. Structural and functional modifications of human aorta proteoglycans in atherosclerosis
22. Engineering non-atherogenic low density lipoproteins: Direct evidence for the "response-to-retention" hypothesis of atherosclerosis
23. Expression of "proteoglycan-binding defective LDL" in transgenic mice
24. Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase
25. Overexpressed lipoprotein lipase protects against atherosclerosis in apolipoprotein E knockout mice
26. Effects of heterozygous lipoprotein lipase deficiency on diet-induced atherosclerosis in mice
27. Plasma and vessel wall lipoprotein lipase have different roles in atherosclerosis
28. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo
29. Role of macrophage-derived lipoprotein lipase in lipoprotein metabolism and atherosclerosis
30. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice
31. Lipoprotein lipase in atherosclerosis: Its presence in smooth muscle cells and absence from macrophages
32. Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions
33. Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques
34. Apolipoprotein E localization in human coronary atherosclerotic plaques by in situ hybridization and immunohistochemistry and comparison with lipoprotein lipase
35. Immunohistochemical localization of lipoprotein lipase and apolipoprotein E in human atherosclerotic lesions
36. Lipoprotein lipase (LPL) strongly links native and oxidized low density lipoprotein particles to decorin-coated collagen: Roles for both monomeric and dimeric forms of LPL
37. Apolipoprotein E modulates low density lipoprotein retention by lipoprotein lipase anchored to subendothelial matrix
38. Differentiated macrophages synthesize a heparan sulfate proteoglycan and an over-sulfated proteoglycan that bind lipoprotein lipase
39. Lipoprotein lipase enhances the interaction of low density lipoproteins with artery-derived extracellular matrix proteoglycans
40. Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: Colocalization of biglycan with apolipoproteins
41. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis
42. Purification of lipoprotein lipase from rat post-heparin plasma
43. Interaction of lipoprotein lipase with homogeneous lipid emulsions
44. Interaction of lipoproteins with heparan sulfate proteoglycans and with lipoprotein lipase: Studies by surface plasmon resonance technique
45. Mild oxidation of lipoproteins increases their affinity for surfaces covered by heparan sulfate and lipoprotein lipase
46. Human lipoprotein lipase: The loop covering the catalytic site is essential for interaction with lipid substrates
47. Mutation of tryptophan residues in lipoprotein lipase: Effects on stability, immunoreactivity, and catalytic properties
48. Chymotryptic cleavage of lipoprotein lipase: Identification of cleavage sites and functional studies of the truncated molecule
49. Contribution of the carboxy-terminal domain of lipoprotein lipase to interaction with heparin and lipoproteins
50. Lipoprotein lipase association with lipoproteins involves protein-protein interaction with apolipoprotein B
51. Cell-surface expression of an aminoterminal fragment of apolipoprotein B increases lipoprotein lipase binding to cells
52. Dissociation of LPL and LDL: Effects of lipoproteins and anti-apoB antibodies
53. Binding of low density lipoproteins to lipoprotein lipase is dependent on lipids but not apolipoprotein B
54. High affinity binding between lipoprotein lipase and lipoproteins involves multiple ionic and hydrophobic interactions, does not require enzyme activity, and is modulated by glycosaminoglycans
55. Not the mature 56 kDa lipoprotein lipase protein but a 37 kDa protein co-purifying with the lipase mediates the binding of low density lipoproteins to J774 macrophages
56. Modified LDL: Trigger of atherosclerosis and inflammation in the arterial intima
57. Aggregation, fusion, and vesicle formation of modified LDL particles: Molecular mechanisms and effects on matrix interactions
58. Oxidation of low density lipoprotein particles decreases their ability to bind to human aortic proteoglycans: Dependence on oxidative modification of the lysine residues
59. Oxidation of low density lipoproteins greatly enhances their association with lipoprotein lipase anchored to endothelial cell matrix
60. Structure of low density lipoprotein (LDL) particles: Basis for understanding molecular changes in modified LDL
61. Lipoprotein lipase-mediated selective uptake from low density lipoprotein requires cell surface proteoglycans and is independent of scavenger receptor class B type 1
62. Release of endothelial cell lipoprotein lipase by plasma lipoproteins and free fatty acids
63. Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo: Molecular size as a determinant of fractional loss from the intima-inner media
64. Retention of fluorescent-labelled chylomicron remnants within the intima of the arterial wall: Evidence that plaque cholesterol may be derived from post-prandial lipoproteins
65. Direct visualization of lipid deposition and reverse lipid transport in a perfused artery: Roles of VLDL and HDL
66. Liposome-like particles isolated from human atherosclerotic plaques are structurally and compositionally similar to surface remnants of triglyceride-rich lipoproteins
67. Lipoprotein lipase increases lipoprotein binding to the artery wall and increases endothelial layer permeability by formation of lipolysis products
68. Lipoprotein lipase regulates Fc receptor-mediated phagocytosis by macrophages maintained in glucose-deficient medium
69. Differentiation of human monocytes to monocyte-derived macrophages is associated with increased lipoprotein lipase-induced tumor necrosis factor-alpha expression and production: A process involving cell surface proteoglycans and protein kinase C
70. Fatty acids modulate the composition of extracellular matrix in cultured human arterial smooth muscle cells by altering the expression of genes for proteoglycan core proteins
71. Direct regulatory effect of fatty acids on macrophage lipoprotein lipase: Potential role of PPARs
72. Lipoprotein lipase can function as a monocyte adhesion protein
73. Lipoprotein lipase enhances human monocyte adhesion to aortic endothelial cells
74. The heparin-binding proteins apolipoprotein E and lipoprotein lipase enhance cellular proteoglycan production
75. Proliferative effect of lipoprotein lipase on human vascular smooth muscle cells